… B and V L , respectively, the product Δ P · Δ V is particularly small … of P B · V L on both sides
of the equation yields Δ P · V L = P B · Δ V , which can be rearranged into V L = P B · Δ V Δ P . …

… (p≤0.017). The next morning active treatment continued to show clinically and statistically
significant benefits (p… night-time relief (p<0.0001) and greater satisfaction on sleep (p=0.002). …

… CAT scores clearly distinguished between SGRQ score categories (quartiles); the differences
between all categories was statistically significant (all p<0.0001) (table 3). CAT scores also …

… Vogelmeier C, Wencker M, Glaab T, Kardos P. Combination therapy with salmeterol and
fluticasone propionate (SFC) improves quality of life (QOL) more than salmeterol (SAL) alone in …

… , a number of them are P-gp substrates, which may saturate P-gp and then mask the effects
… well-known P-gp substrates in the present study, as listed in Table 3 (bold font). In the P-gp …

Pan-European data on health-related quality of life (HRQL) in chronic obstructive pulmonary
disease (COPD) are lacking. This cross-sectional epidemiological study evaluated health …

Background Gastroesophageal reflux disease (GERD) is one of the most frequent benign
disorders of the upper gastrointestinal tract. Management of GERD has always been …

Acute respiratory tract infections, i. e. rhinitis, sinusitis, pharyngitis, laryngitis, bronchitis, belong
to the most common medical conditions with a high economic burden. Nonetheless, there …

… The peak dose of 0.6 mL strength B contains 7 μg Der p 1 and 6 μg Der p 2. Initial therapy
consisted of weekly injections with increasing doses of strength A (0.1, 0.2, 0.4, and 0.6 mL) …

… (p = 0.044 vs. formoterol); FEV 1 5 min after the first dose (p < 0.001) and at 12 weeks (p < …
tiotropium); and peak expiratory flow averaged over the first 6 weeks (p < 0.001 vs. both). The …